中科生物(01237.HK):根據美國商務部裁定若干出口至美國的木製品加權平均傾銷率為79.4%
格隆匯8月11日丨中科生物(01237.HK)公告,繼2020年1月29日宣佈啟動調查之後,2020年8月5日,美國商務部宣佈對從中國進口的木模製品和木製品的反傾銷税調查作出正面的初步裁定,出口商的加權平均傾銷率為40.3%至146.91%。商務部將指示美國海關和邊境保護局,向該產品的進口商收取費率為29.57%至136.18%的保證金。
根據上述初步裁定,集團旗下全資附屬公司,福建省漳平木村林產有限公司被裁定其若干出口至美國的木製品的加權平均傾銷率為79.4%。受該初步裁定的影響,美國海關和邊境保護局將向該等產品的進口商收取費率為68.67%的保證金。集團目前正就該保證金與其美國客户與進行談判。
商務部進一步宣佈,商務部將於初步裁定後不遲於135天作出最終裁定。如果商務部做出正面的最終裁定,美國國際貿易委員會將於最終裁定的45天內作出就該產品是否對美國有關產業正在或構成重大損害作出最終裁定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.